The Riverside Company has acquired Red Nucleus Enterprises to add to its life sciences training and education platform. Terms were not disclosed. 

Red Nucleus, which was owned by Wayne, Pa.-based PE firm Renovus Capital Partners, provides learning and compliance services to customers in the pharmaceutical industry.

“RN is a premium partner to the world’s leading pharmaceutical companies, offering training to help launch and commercialize their products,” Riverside Managing Partner Suzy Kriscunas said in a statement. “With their already established relationships with blue-chip companies, we look to expand training offerings and build out technological capabilities during our partnership.”

Red Nucleus specializes in adult learning in the life sciences industry, leveraging its training and technical expertise to convey strategy and information to global sales teams, medical liaisons and others.

“This is an exciting investment for us as Riverside has relevant experience with taking a training business and transforming it into a diversified tech-enabled training and compliance platform through organic and investment initiatives – we’ve done this successfully with other platforms such as HSI and Alchemy, for example,” Riverside Partner Peter Tsang said. “We’re actively looking for add-ons for this investment, hoping to expand its service offerings and global geographic footprint.”

Working with Kriscunas and Tsang on the deal for Riverside were Partner Steve Burns, Principal Jason Fulton, Senior Associate John Ribble, Associate Nesh Faatimah, Associate Mark Fishman, Capital Markets Partner Anne Hayes, Operating Partner Mark Reed and Operating Finance Executive Rob Carraway.